Ignyta's Pending Acquisition

Ignyta raised a round of funding on December 22, 2017. Investors include Roche Holding.

Ignyta, formerly NexDx, specializes in precision medicine and biotechnology, with an integrated Rx/Dx approach in oncology, for the benefit of cancer patients everywhere.…

Articles about Ignyta's Pending Acquisition: